AxoGen, Inc. Stock price

Equities

AXGN

US05463X1063

Advanced Medical Equipment & Technology

Market Closed - Nasdaq 04:30:00 2024-03-28 pm EDT 5-day change 1st Jan Change
8.07 USD +3.86% Intraday chart for AxoGen, Inc. +5.22% +18.16%
Sales 2024 * 179M Sales 2025 * 201M Capitalization 349M
Net income 2024 * -18M Net income 2025 * -1M EV / Sales 2024 * 1.94 x
Net cash position 2024 * - Net cash position 2025 * - EV / Sales 2025 * 1.73 x
P/E ratio 2024 *
-18.8 x
P/E ratio 2025 *
-242 x
Employees 427
Yield 2024 *
-
Yield 2025 *
-
Free-Float 92.38%
More Fundamentals * Assessed data
Dynamic Chart
1 day+3.86%
1 week+5.22%
Current month-23.58%
1 month-21.88%
3 months+17.30%
6 months+59.49%
Current year+18.16%
More quotes
1 week
7.31
Extreme 7.3126
8.11
1 month
7.31
Extreme 7.3126
10.83
Current year
6.52
Extreme 6.52
10.83
1 year
3.45
Extreme 3.45
10.83
3 years
3.45
Extreme 3.45
23.94
5 years
3.45
Extreme 3.45
25.84
10 years
2.11
Extreme 2.11
56.85
More quotes
Managers TitleAgeSince
Chief Executive Officer 62 06-04-30
Director of Finance/CFO 50 Dec. 05
Chief Tech/Sci/R&D Officer 69 18-08-31
Members of the board TitleAgeSince
Director/Board Member 68 20-09-29
Director/Board Member 63 16-08-31
Director/Board Member 66 21-07-18
More insiders
Date Price Change Volume
24-03-28 8.07 +3.86% 172,095
24-03-27 7.77 +2.91% 296,087
24-03-26 7.55 +1.75% 159,681
24-03-25 7.42 +0.95% 162,652
24-03-22 7.35 -4.17% 126,188

Delayed Quote Nasdaq, March 28, 2024 at 04:30 pm EDT

More quotes
Axogen, Inc. is focused on the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. It offers repair solutions for surgeons and healthcare providers. Its products include Avance nerve graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, Axotouch Two-Point Discriminator and Axoguard HA+ Nerve Protector. Avance nerve graft is a biologically active processed human nerve allograft for bridging severed peripheral nerves without the comorbidities associated with a second surgical site. Axoguard Nerve Connector is a porcine submucosa extracellular matrix coaptation aid for tensionless repair of severed peripheral nerves. Axoguard Nerve Protector is a porcine submucosa ECM product used to wrap and protect damaged peripheral nerves and reinforce nerve reconstruction while preventing soft tissue attachment. Axotouch Two-Point Discriminator is used to measure the innervation density of any surface area of the skin.
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
8.07 USD
Average target price
13.8 USD
Spread / Average Target
+71.00%
Consensus
  1. Stock
  2. Equities
  3. Stock AxoGen, Inc. - Nasdaq